Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 8.84% is in line with its 5-year average of 9.38%, around the middle of its 5-year range (6.79%–11.58%).
As of the fiscal period ended Wednesday, December 31, 2025. 3.21% above its 12-month average of 8.56%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
8.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
8.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
8.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
9.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.21%
CURRENT VS 3Y AVG
+5.62%
CURRENT VS 5Y AVG
-5.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.65%
median of 72 covered companies
CURRENT VS SECTOR MEDIAN
+2.14%
vs the sector median at left
GE HealthCare Technologies Inc.
Market Cap
$33.28B
Return on Invested Capital (ROIC)
8.84%
TTM Avg
8.56%
3Y Avg
8.37%
5Y Avg
9.38%
Market Cap
$33.33B
Return on Invested Capital (ROIC)
-13.41%
TTM Avg
-4.17%
3Y Avg
-0.53%
5Y Avg
0.76%
Market Cap
$33.87B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
13.40%
3Y Avg
11.07%
5Y Avg
9.62%
Market Cap
$32.56B
Return on Invested Capital (ROIC)
19.11%
TTM Avg
19.34%
3Y Avg
17.94%
5Y Avg
17.11%
Market Cap
$31.00B
Return on Invested Capital (ROIC)
6.62%
TTM Avg
7.71%
3Y Avg
8.64%
5Y Avg
10.90%
Market Cap
$30.93B
Return on Invested Capital (ROIC)
21.54%
TTM Avg
21.87%
3Y Avg
20.30%
5Y Avg
19.27%
Market Cap
$30.83B
Return on Invested Capital (ROIC)
17.57%
TTM Avg
18.00%
3Y Avg
20.73%
5Y Avg
22.79%
Market Cap
$30.60B
Return on Invested Capital (ROIC)
13.74%
TTM Avg
4.77%
3Y Avg
-7.01%
5Y Avg
-13.46%
Market Cap
$30.22B
Return on Invested Capital (ROIC)
5.69%
TTM Avg
6.03%
3Y Avg
3.95%
5Y Avg
3.95%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (GEHC) | $33.28B | 8.84% | 8.56% | 8.37% | 9.38% |
| Centene Corp. (CNC)vs › | $33.33B | -13.41% | -4.17% | -0.53% | 0.76% |
| DexCom, Inc. (DXCM)vs › | $33.87B | 16.61% | 13.40% | 11.07% | 9.62% |
| ResMed Inc. (RMD)vs › | $32.56B | 19.11% | 19.34% | 17.94% | 17.11% |
| Biogen Inc. (BIIB)vs › | $31.00B | 6.62% | 7.71% | 8.64% | 10.90% |
| Zoetis Inc. (ZTS)vs › | $30.93B | 21.54% | 21.87% | 20.30% | 19.27% |
| Waters Corporation (WAT)vs › | $30.83B | 17.57% | 18.00% | 20.73% | 22.79% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $30.60B | 13.74% | 4.77% | -7.01% | -13.46% |
| Medline Inc. (MDLN)vs › | $30.22B | 5.69% | 6.03% | 3.95% | 3.95% |
| Mettler-Toledo International Inc. (MTD)vs › | $28.67B | 35.46% | 38.26% | 37.51% | 36.01% |
ROIC
8.8%
ROE
14.5%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 8.84% |
| 2024-12-31 | 8.29% |
| 2023-12-31 | 6.79% |
| 2022-12-31 | 9.56% |
| 2021-12-31 | 11.25% |
| 2020-12-31 | 11.58% |
| 2019-12-31 | 0.00% |
